Zhongguancun high-tech enterprise

Since its establishment, Zhongguancun Medical Engineering Transformation Center has actively provided integrated scientific and technological innovation and entrepreneurship chain services for Chinese medicine, biomedicine and medical device enterprises at different stages of development at home and abroad, helping enterprises to achieve comprehensive breakthroughs and step into the track of benign, healthy and sustainable development. A few days ago, the website of Beijing Science and Technology Commission and Zhongguancun Science Park Management Committee released Zhongguancun High-tech Enterprise Library (as of June 2022 1) and the list of Gazelle enterprises in 20021year. In Zhongguancun National Independent Innovation Demonstration Zone, seven enterprises introduced and served by Zhongguancun Medical Engineering Transformation Center (referred to as Transformation Center) entered Zhongguancun high-tech enterprise library, and three of them also entered the list of Gazelle enterprises. This time, 25,406 enterprises entered the Zhongguancun High-tech Enterprise Library, involving electronic information, advanced manufacturing technology, bioengineering, new medicine and other fields 1 1, including 2,046 enterprises with advanced manufacturing technology and 755 enterprises with bioengineering and new medicine. Among the enterprises introduced and served by the transformation center, there are 6 bioengineering and new medicine enterprises and 6 advanced manufacturing technology enterprises 1 company. Zhongguancun High-tech Enterprise Library and the Selected List of Its Technical Fields (including only the enterprises introduced and served by the transformation center) Zhongguancun High-tech enterprises refer to the high-tech fields supported by the state in Zhongguancun Science Park. Through the continuous research and development and transformation of technological achievements, the core independent intellectual property rights of enterprises are formed, and on this basis, business activities are carried out to transform major high-tech achievements into productivity, which belongs to domestic or international advanced enterprises. Zhongguancun high-tech enterprise certification is approved and issued by Beijing Zhongguancun Science Park Management Committee, which has a series of strict requirements on the qualification, R&D strength, profitability and development ability of the enterprise, and has strict certification procedures. Gazelle Enterprises Previously, the websites of Beijing Science and Technology Commission and Zhongguancun Science Park Management Committee also published the list of gazelle enterprises in 20021year, and * * * 5,629 enterprises were shortlisted. Among them, three enterprises introduced by the transformation center-Beijing Ji Hua Abby Biotechnology Co., Ltd., Beijing Jieyalaifu Biotechnology Co., Ltd. and Zhongguancun International Medical Inspection and Certification Technology Co., Ltd. were selected, and these three enterprises are also high-tech enterprises in Zhongguancun. Gazelle enterprises include "Gazelle Project" enterprises and key gazelle cultivation enterprises. In order to improve the financing environment of small and medium-sized high-tech enterprises in Zhongguancun Science Park, the management committee of Zhongguancun Science Park has formulated "Gazelle Plan" and "Several Financial Measures to Support the Development of Gazelle Key Cultivation Enterprises in Zhongguancun National Independent Innovation Demonstration Zone (Revised)", evaluated the "Gazelle Plan" enterprises and gazelle key cultivation enterprises according to certain standards, and given certain preferential measures to the selected enterprises. Zhongguancun International Medical Inspection and Certification Technology Co., Ltd. was established on 20 15. It is a national high-tech enterprise specializing in the inspection and testing of disinfection products, food, cosmetics, water quality and wading products. Headquartered in Beijing, the company has set up wholly-owned branches in Chongqing and Fujian, with more than 5,000 testing capabilities certified by CMA and more than 600 testing capabilities certified by CNAS. Achieve full coverage of testing items in disinfection products, and the food testing capacity covers more than 98% of the food safety sampling items of the State Administration of Market Supervision. Watson Crick (Beijing) Biotechnology Co., Ltd. was established on 20 15, which is a national high-tech biotechnology group company engaged in the rapid development of life bank and cell health care. The company is recognized as a national high-tech enterprise and Zhongguancun high-tech enterprise, and is a patent pilot unit in Beijing. Its gene technology, sample bank technology and cell technology have also obtained ISO900 1—20 15 international quality system certification, and it is the key laboratory of Zhongguancun Medical Transformation Center, the member unit of Beijing Regional Cell Preparation Center, China Medical Biotechnology Association, and the director unit of China Skin and Soft Tissue Repair and Reconstruction Technical Committee. Established in 1994, Beijing Ji Hua Biotechnology Co., Ltd. is a core subsidiary of Shenzhen Huada Gene Co., Ltd., mainly engaged in research and development, production, sales and medical inspection solutions of in vitro diagnostic reagents. It is the first batch of in-vitro diagnostic reagent enterprises that passed GMP certification in China. Over the past 20 years, 100% of blood screening products have been issued in batches of biological products by the State Medical Device Administration, ranking first in the national clinical quality evaluation organized by China Center for Disease Control and Prevention for many times. The company now has technology platforms such as enzyme-linked immunity, chemiluminescence, nucleic acid detection, POCT, mass spectrometry detection, clinical service, biochip joint detection, biochemical detection and gene sequencing. , covering fertility, tumor screening and medication guidance, common diseases, infectious diseases, blood screening, nutritional metabolism and other product lines. Is one of the IVD enterprises with complete platforms in China. Beijing Jieyalaifu Biotechnology Co., Ltd. was established in 1995, and is the first high-tech enterprise engaged in the research, development, production and sales of biological tissue engineering products in China. Has the international level of tissue engineering patent technology. The main products are: J- 1 acellular allogenic dermis, human biological dressing, human soft tissue repair materials and newly developed bone repair materials. Beijing Saiertai Biomedical Technology Co., Ltd. is located in Zhongguancun Science Park, Peking University Science Park, and belongs to national high-tech enterprises, Zhongguancun high-tech enterprises and innovative enterprises in Haidian District. Founded in July, 2006 19, the company was engaged in the research and development of autologous cell therapy technology and tissue engineering technology and products earlier in China, and applied tissue engineering therapy technology and autologous cell therapy technology to clinic. At present, there are 7 patents, all of which belong to the fields of tissue engineering and genetic engineering. Through cooperation with domestic universities and American universities, the company has developed three tissue engineering technologies and applied them in clinic: autologous skin cell repair therapy, autologous corneal epithelial therapy and tissue engineering combined with skin therapy. The company's research technology and products mainly include: neural stem cell therapy products, animal vaccine adjuvant development, gene drug development projects. Beijing watson biological Institute of Technology Co., Ltd. was established on March 5, 20 18, and its business scope includes technology development, technology transfer, technology service and technology consultation of stem cell gene drugs. Medical research and experimental development; Sales of first-class medical devices; Chinese medicine medical service. Beijing Li Wenpu Biotechnology Co., Ltd. was established on March 9, 20 18, and its business scope includes sales of self-developed products, cosmetics and chemical products (excluding dangerous chemicals and a class of precursor chemicals); Medical research and experimental development; Health consultation and health management (except for diagnosis and treatment activities subject to approval).